Mobile O.D.T. LTD of Tel Aviv at MEDICA 2019 in Düsseldorf -- MEDICA - World Forum for Medicine
Manage stand orders
Select Option

Mobile O.D.T. LTD

P.O. Box 57506, 6721832 Tel Aviv
Ben Avigdor 8 3rd Floor, 6721832 Tel Aviv
Israel

This company is co-exhibitor of
Israel Export & International Cooperation Institute

Hall map

MEDICA 2019 hall map (Hall 16): stand M25

Fairground map

MEDICA 2019 fairground map: Hall 16

Contact

Noam Sorek

Head of International Sales

Phone
+972 54-617-7402

Email
noamsorek@mobileodt.com

Yael Misrahi

Head of Global Partnerships

Phone
+44 7474 219544

Email
yaelmisrahi@mobileodt.com

Our range of products

Product categories

  • 01  Electromedical Equipment / Medical Technology
  • 01.01  Diagnostics
  • 01.01.04  Colposcopes, equipment for gynaecological investigation and diagnosis

Colposcopes, equipment for gynaecological investigation and diagnosis

Our products

Product category: Colposcopes, equipment for gynaecological investigation and diagnosis

The EVA System

MobileODT helps clinicians utilize the power of AI through portable medical devices to enhance women’s health. Our Enhanced Visual Assessment (EVA) System is saving lives by enabling early detection for cervical cancer.  The CE-marked and FDA-cleared smart mobile colposcope is used by clinicians in over 40 countries and across more than 60 US health systems for colposcopy, general gynecology, tele-colposcopy, and forensic imaging. 

As a mobile and affordable colposcope, the EVA System drastically improves accessibility to expert care by enabling remote collaboration and online medical documentation. MobileODT is integrating its Augmented Intelligence (AI) in approved markets to provide powerful clinical decision support to healthcare providers. The AI breakthrough of the Automated Visual Evaluation (AVE) algorithm announced by the US National Cancer Institute in January 2019, will enable healthcare providers to detect cervical cancer and at the point-of-care in less than one second, with a single image of the cervix taken on the EVA System, enabling a ‘screen and treat’ offering to be available worldwide

More Less

About us

Company details

MobileODT helps clinicians utilize the power of AI through portable medical devices to enhance women’s health. Combining advanced imaging, data and software applications, MobileODT’s Enhanced Visual Assessment (EVA) System is saving lives by enabling early detection for cervical cancer.  The CE-marked and FDA-cleared smart mobile colposcope is used by clinicians in over 40 countries and across more than 60 US health systems for colposcopy, general gynecology, tele-colposcopy, and forensic imaging. 


As a mobile and affordable colposcope, the EVA System drastically improves accessibility to expert care by enabling remote collaboration and online medical documentation. MobileODT is integrating its Augmented Intelligence (AI) in approved markets to provide powerful clinical decision support to healthcare providers. The AI breakthrough of the Automated Visual Evaluation (AVE) algorithm announced by the US National Cancer Institute in January 2019, will enable healthcare providers to detect cervical cancer and at the point-of-care in less than one second, with a single image of the cervix taken on the EVA System, enabling a ‘screen and treat’ offering to be available worldwide.

More Less

Company data

Number of employees

50-99

Area of business

Diagnostics